202798-06-9

Basic information

• Product Name: 4-PENT-1-ENYL-BENZOIC ACID
• Synonyms: 4-PENT-1-ENYL-BENZOIC ACID ;4-(pent-1-en-1-yl)benzoic acid;(E)-4-(PENT-1-EN-1-YL)BENZOIC ACID
• CAS NO: 202798-06-9
• Molecular Formula: C12H14O2
• Molecular Weight: 190.23836
• Mol File: 202798-06-9.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 335.019 °C at 760 mmHg
• Flash Point: 156.662 °C
• Appearance: /
• Density: 1.081 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.577
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-PENT-1-ENYL-BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 4-PENT-1-ENYL-BENZOIC ACID(202798-06-9)
• EPA Substance Registry System: 4-PENT-1-ENYL-BENZOIC ACID(202798-06-9)

Safety Data

• Hazardous Substances Data: 202798-06-9(Hazardous Substances Data)

Usage

General Description

4-PENT-1-ENYL-BENZOIC ACID, also known as 4-pent-1-enylbenzoic acid, is a chemical compound with the molecular formula C12H14O2. It is a derivative of benzoic acid and contains a pentenyl group attached to the benzene ring. 4-PENT-1-ENYL-BENZOIC ACID is utilized in the synthesis of various pharmaceuticals and agrochemicals, and it also possesses potential for use in the development of new materials and flavors. 4-Pent-1-enyl-benzoic acid has the potential to exhibit biological activity due to its structural characteristics, and its synthesis and properties are of interest for research in the fields of chemistry, pharmaceuticals, and materials science.

InChI:InChI=1/C12H14O2/c1-2-3-4-5-10-6-8-11(9-7-10)12(13)14/h4-9H,2-3H2,1H3,(H,13,14)/b5-4+

Upstream product

• 502-56-7 nonanone-5 
• 619-66-9 4-Carboxybenzaldehyde 

Relevant articles and documents

AMIDE DERIVATIVES AS ION CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Abstract of the Disclosure Compounds are disclosed that have a formula represented by Formula I herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals in

New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture

The present invention relates to carboxamide compounds of general formula I wherein the groups and residues A, B, W, X, Y, Z, R1, R2, R3 and k have the meanings given in claim 1. Moreover the invention relates to process for preparing the above mentioned carboxamides as well as pharmaceutical compositions containing at least one carboxamide according to the invention. In view of their MCH-receptor antagonistic activity the pharmaceutical compositions according to the invention are suitable for the treatment of metabolic disorders and/or eating disorders, particularly obesity, bulimia, anorexia, hyperphagia and diabetes.